Together these in vitro and in vivo results indicated that loss of AR activity in response to androgen deprivation at AR/MYC co-regulated genes is buffered by an increase in MYC, along with an increase in expression of MYC-unique genes that may further enhance tumor growth. The gene discussed is MYC; the disease is neoplasm.